Article

Hematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-Line Treatment With A Bortezomib-Based Regimen

2021-01-28

Abstract excerpt

<h4>Background: </h4> It is very important to evaluate the prognosis of multiple myeloma (MM) patients before starting treatment. Although hematopoietic status may have a significant impact on patient survival, it has not received sufficient attention in current clinical practice. <h4>Methods: </h4>: This was a retrospective study of 328 newly diagnosed MM patients received first-line treatment with a bortezomib-b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b4e9f413-2179-58f8-aa1c-7211db1c0d33
DOI: 10.21203/rs.3.rs-137751/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Hematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-Line Treatment With A Bortezomib-Based RegimenDOI 10.21203/rs.3.rs-137751/v1Read

Haematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-line Treatment With a Bortezomib-based RegimenSemantic proximity Read

Increased LDH Remains a Crucial Prognostic Factor in Patients with Multiple Myeloma.Semantic proximity Read

Analysis of clinical characteristics and prognostic factors of multiple myeloma: a retrospective single-center study of 787 cases.Semantic proximity Read

International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantationSemantic proximity Read

Treatment outcome of newly diagnosed multiple myeloma patients: A retrospective analysis in a resource-limited settingSemantic proximity Read

Functional high-risk phenotype predicts poor survival in multiple myeloma independent of front-line treatment: A secondary analysis of CIBMTR data.Semantic proximity Read

Pattern of Use and Efficacy of Daratumumab-based Therapy in Patients With Multiple Myeloma in a Real-world Setting: a Single Institution ExperienceSemantic proximity Read

Correlation analysis of circulating myeloma cells with tumor load, angiogenesis and disease progression of multiple myeloma and clinical significanceSemantic proximity Read

Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literatureSemantic proximity Read

Cytogenetic and clinical marks for defining high-risk myeloma in the context of bortezomib treatment.Semantic proximity Read

Analysis of long‐term survival in multiple myeloma after first‐line autologous stem cell transplantation: impact of clinical risk factors and sustained responseSemantic proximity Read

Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answersSemantic proximity Read